Sagartz John E 4
4 · BIOANALYTICAL SYSTEMS INC · Filed Dec 4, 2019
Insider Transaction Report
Form 4
Sagartz John E
Chief Strategy Officer
Transactions
- Award
Common Shares
2019-12-02+8,974→ 630,499 total
Footnotes (2)
- [F1]Represents restricted grant subject to vesting and forfeiture.
- [F2]Of the 630,499 shares reported, 617,625 shares were previously reported as indirectly held. These shares were distributed to the reporting person as part of a pro-rata distribution from SW Chrysalis, LLC, of which the reporting person is the Co-President and Chief Strategy Officer.